Haimaide Venture Capital

Haimaide Venture Capital, also known as Shanghai Haimaide Chuangye Touzi Guanli Youxian Gongsi, is a venture capital firm based in Shanghai, China, that invests in early-stage technology companies. The firm primarily targets innovative startups leveraging advanced technologies, with a particular emphasis on artificial intelligence and biotechnology, including cytological diagnosis solutions. Its investment strategy supports companies developing disruptive solutions in these high-growth sectors, exemplified by its backing of Cytowiz Incorporated, a key player in cytological diagnosis technologies. While specific details on total assets under management or the full breadth of its portfolio remain undisclosed, Haimaide Venture Capital actively seeks to identify and nurture promising ventures within the Chinese tech ecosystem. The firm's commitment is to foster innovation and growth in critical technological domains.